Spruce Biosciences Ownership | Who Owns Spruce Biosciences?


OverviewForecastRevenueFinancialsChartTranscripts

Spruce Biosciences Ownership Summary


Spruce Biosciences is owned by 4.78% institutional investors, 11.73% insiders, and 83.49% retail investors. Rivervest venture management is the largest institutional shareholder, holding 7.14% of SPRB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.55% of its assets in Spruce Biosciences shares.

SPRB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSpruce Biosciences4.78%11.73%83.49%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rivervest venture management2.94M7.14%$1.52M
Rock springs capital management lp2.61M6.32%$1.10M
Acadian asset management1.05M2.44%$74.00K
Ikarian capital1.00M2.33%$72.50K
Blackrock124.73K0.30%$64.58K
Susquehanna group, llp58.98K0.14%$24.77K
Charles schwab investment management15.29K0.04%$7.92K
Citadel advisors14.30K0.03%$7.40K
Morgan stanley2.13K0.01%$1.10K
Caldwell sutter capital1.00K0.00%$73.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rivervest venture management2.94M22.27%$1.52M
Rock springs capital management lp2.61M0.04%$1.10M
Ikarian capital1.00M0.01%$72.50K
Acadian asset management1.05M0.00%$74.00K
Two sigma advisers, lp---
Tower research capital llc (trc)---
Renaissance---
Two sigma securities---
Blackrock124.73K-$64.58K
Lion point capital, lp---

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp58.98K-58.98K
Citadel advisors14.30K-4.40K
Bnp paribas arbitrage, snc181.00-181.00
Rivervest venture management2.94M22.27%-
Caldwell sutter capital1.00K--

Top Sellers

HolderShares% AssetsChange
Carlyle group---2.90M
Rosalind advisors---1.51M
Aisling capital management lp---1.21M
Vanguard group---843.84K
Altium capital management lp---811.17K

New Positions

HolderShares% AssetsChangeValue
Susquehanna group, llp58.98K-58.98K$24.77K
Bnp paribas arbitrage, snc181.00-181.00$76.00

Sold Out

HolderChange
Qube research-2.00
Jpmorgan chase-65.00
Fmr-103.00
Wells fargo & company/mn-143.00
Group one trading-1.15K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20253-89.29%2,046,828-73.79%41.51%--100.00%--100.00%
Mar 31, 202530-10,436,800-6.52%233.25%10-9.09%7-30.00%
Dec 31, 202430-6.25%11,164,918-17.90%272.49%1137.50%10-9.09%
Sep 30, 202432-20.00%13,598,951-17.95%322.02%8-20.00%11-26.67%
Jun 30, 202440-24.53%16,573,655-7.76%402.10%10-68.75%1587.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF638.56K1.55%-
Vanguard Total Stock Mkt Idx Inv638.56K1.55%-
Vanguard Institutional Extnd Mkt Idx Tr197.19K0.48%-
Fidelity Extended Market Index147.81K0.36%-942.00
Fidelity Series Total Market Index36.51K0.09%-
Bridgeway Ultra-Small Company Market34.90K0.08%-5.10K
Fidelity Total Market Index31.50K0.08%-
Spartan Extended Market Index Pool F30.59K0.07%942.00
Spartan Extended Market Index Pool E30.59K0.07%942.00
Vanguard Instl Ttl Stck Mkt Idx Tr19.53K0.05%19.53K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 21, 2024Novo Holdings A/S-Sell$350.95K
Mar 19, 2024Novo Holdings A/S-Sell$447.71K
Mar 18, 2024Novo Holdings A/S-Sell$647.01K
Mar 20, 2024Novo Holdings A/S-Sell$264.08K
Mar 14, 2024Novo Holdings A/S-Sell$1.70M

Insider Transactions Trends


DateBuySell
2025 Q3--
2024 Q4--
2024 Q2--
2024 Q1-5
2023 Q4--

SPRB Ownership FAQ


Who Owns Spruce Biosciences?

Spruce Biosciences shareholders are primarily institutional investors at 4.78%, followed by 11.73% insiders and 83.49% retail investors. The average institutional ownership in Spruce Biosciences's industry, Biotech Stocks , is 306.59%, which Spruce Biosciences falls below.

Who owns the most shares of Spruce Biosciences?

Spruce Biosciences’s largest shareholders are Rivervest venture management (2.94M shares, 7.14%), Rock springs capital management lp (2.61M shares, 6.32%), and Acadian asset management (1.05M shares, 2.44%). Together, they hold 15.90% of Spruce Biosciences’s total shares outstanding.

Does Blackrock own Spruce Biosciences?

Yes, BlackRock owns 0.30% of Spruce Biosciences, totaling 124.73K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 64.58K$. In the last quarter, BlackRock decreased its holdings by -61.214K shares, a -32.92% change.

Who is Spruce Biosciences’s biggest shareholder by percentage of total assets invested?

Rivervest venture management is Spruce Biosciences’s biggest shareholder by percentage of total assets invested, with 22.27% of its assets in 2.94M Spruce Biosciences shares, valued at 1.52M$.

Who is the top mutual fund holder of Spruce Biosciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Spruce Biosciences shares, with 1.55% of its total shares outstanding invested in 638.56K Spruce Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools